Cargando…
The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad
Gujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%.
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Medknow Publications & Media Pvt Ltd
2013
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902622/ https://www.ncbi.nlm.nih.gov/pubmed/24516307 http://dx.doi.org/10.4103/0971-5851.123729 |
| _version_ | 1782301015895179264 |
|---|---|
| author | Shah, Sandip A. |
| author_facet | Shah, Sandip A. |
| author_sort | Shah, Sandip A. |
| collection | PubMed |
| description | Gujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%. |
| format | Online Article Text |
| id | pubmed-3902622 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2013 |
| publisher | Medknow Publications & Media Pvt Ltd |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-39026222014-02-10 The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad Shah, Sandip A. Indian J Med Paediatr Oncol Original Article Gujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%. Medknow Publications & Media Pvt Ltd 2013 /pmc/articles/PMC3902622/ /pubmed/24516307 http://dx.doi.org/10.4103/0971-5851.123729 Text en Copyright: © Indian Journal of Medical and Paediatric Oncology http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Original Article Shah, Sandip A. The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad |
| title | The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad |
| title_full | The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad |
| title_fullStr | The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad |
| title_full_unstemmed | The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad |
| title_short | The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad |
| title_sort | treatment of chronic myeloid leukemia, data from gujarat cancer and research institute, ahmedabad |
| topic | Original Article |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902622/ https://www.ncbi.nlm.nih.gov/pubmed/24516307 http://dx.doi.org/10.4103/0971-5851.123729 |
| work_keys_str_mv | AT shahsandipa thetreatmentofchronicmyeloidleukemiadatafromgujaratcancerandresearchinstituteahmedabad AT shahsandipa treatmentofchronicmyeloidleukemiadatafromgujaratcancerandresearchinstituteahmedabad |